Bank of Nova Scotia’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bank of Nova Scotia’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.5K	Buy	+11,178	New	+$37.4K	﹤0.01%	1061

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Nova Scotia's NBP Position: Q1 2026 in Review

Bank of Nova Scotia opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 11,178 shares worth $27.5K. The stake represents ﹤0.01% of the portfolio and ranks #1061 among its holdings.

48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Bank of Nova Scotia held 11,178 shares of NovaBridge Biosciences American Depositary Shares worth $27.5K as of Q1 2026.
NovaBridge Biosciences American Depositary Shares was a new Bank of Nova Scotia position in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #1061 holding.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.